Stemgent
Graeme Macluskie has extensive experience in the field of precision medicine and research and development. Currently, Graeme serves as the Director of Precision Medicine at REPROCELL, where the focus is on developing and expanding collaborations and opportunities for the company. Previously, at REPROCELL Europe, Graeme held the position of Head of Research and Development, overseeing the expansion and refinement of the company's range of predictive drug discovery assays. Prior to REPROCELL, Graeme worked at Aptuit as a Senior Supervisor/Study Director within the DMPK group, managing various in-vivo and in-vitro DMPK studies. Graeme holds a BSc (Hons) in Biochemistry and Pharmacology from the University of Strathclyde.
This person is not in any teams
This person is not in any offices
Stemgent
Stemgent is a provider of reagents, services and training for scientists who study cellular reprogramming (iPS cells).